Objectives of the Research Program. The objectives of the Research Program shall be the identification of Ab-MAY Products directed to one or more Holding Option Targets and Reserve Option Targets that (i) consist of one or more Lilly Antibodies conjugated to one or more MAY Compounds and (ii) are suitable for further development and commercialization as Licensed Products under an Exclusive License.
Appears in 4 contracts
Samples: Confidential Treatment Requested (Immunogen Inc), Confidential Treatment Requested (Immunogen Inc), License Agreement (Immunogen Inc)
